Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine

Journal of Neurochemistry

Volumn 68, Issue 5, 1997, Pages 2032-2037

  Kuczenski, Ronald ^a   Segal, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; C audate putamen; Dopamine; Hippocampus; Methylphenidate; Microdialysis; Norepinephrine; Serotonin

Indexed keywords

AMPHETAMINE; DOPAMINE; METHYLPHENIDATE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PUTAMEN; RAT; SEROTONINERGIC SYSTEM; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030949516     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68052032.x     Document Type: Article

References (44)

1. 3H] GBR12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J. Neurochem. 48, 1887-1896.
2. Andersen P. H. (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493-504.
3. Antelman S. M. and Caggiula A. R. (1996) Norepinephrine-dopamine interactions and behavior. Science 195, 646-653.
4. Benveniste H., Hansen A. J., and Ottosen N. S. (1989) Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52, 1741-1750.
5. Breese G. R., Cooper B. R., and Mueller R. A. (1974) Evidence for involvement of 5-hydroxytryptamine in the action of amphetamine. Br. J. Pharmacol. 52, 307-314.
6. Brodie B. B. and Shore P. A. (1957) A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann. NY Acad. Sci. 66, 631-642.
7. Browne R. G. and Segal D. S. (1977) Metabolic and experiential factors in the behavioral response to repeated amphetamine. Pharmacol. Biochem. Behav. 6, 545-552.
8. Butcher S. P., Liptrot J., and Aburthnott G. W. (1991) Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122, 245-248.
9. Church W. H. and Justice J. B. Jr. (1987) Rapid sampling and determination of extracellular dopamine. Anal. Chem. 59, 712-716.
10. During M. J., Bean A. J., and Roth R. H. (1992) Effect of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci. Lett. 140, 129-133.
11. Ferris R. M., Tang F. L. M., and Maxwell R. A. (1972) A comparison of the capacities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J. Pharmacol. Exp. Ther. 181, 407-416.
12. Florin S. M., Kuczenski R., and Segal D. S. (1994) Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res. 654, 53-62.
13. Florin S. M., Kuczenski R., and Segal D. S. (1995) Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations. J. Pharmacol. Exp. Ther. 274, 231-241.
14. Gately P. F., Poon S. L., Segal D. S., and Geyer M. A. (1985) Depletion of brain serotonin induced 5,7-dihydroxytryptamine alters the habituation of locomotor activity and the response to amphetamine in rats. Psychopharmacology (Berl.) 87, 400-405.
15. Gatley S. J., Pan D. F., Chen R. Y., Chaturvedi G., and Ding Y. S. (1996) Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 58, PL231-PL239.
16. Geyer M. A., Puerto A., Menkes D. B., Segal D. S., and Mandell A. J. (1976) Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106, 257-270.
17. Geyer M. A., Masten G., and Segal D. S. (1986) Behavioral effects of xylamine-induced depletions of brain norepinephrine: interactions with amphetamine. Behav. Brain Res. 21, 55-64.
18. Holman K. B. (1994) Biological effects of central nervous system stimulants. Addiction 89, 1435-1441.
19. Hurd Y. L. and Ungerstedt U. (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166, 251-260.
20. Kuczenski R. and Segal D. S. (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9, 2051-2065.
21. Kuczenski R. and Segal D. S. (1992a) Regional norepinephrine response to amphetamine using dialysis: comparison to caudate dopamine. Synapse 11, 164-169.
22. Kuczenski R. and Segal D. S. (1992b) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085-1094.
23. Kuczenski R., Segal D. S., and Aizenstein M. L. (1991) Amphetamine, fencamfamine, and cocaine: relationships between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11, 2703-2712.
24. Kuczenski R., Segal D. S., Cho A. K., and Melega W. P. (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15, 1308-1317.
25. Mabry P. D. and Campbell B. A. (1973) Serotonergic inhibition of catecholamine-induced behavioral arousal. Brain Res. 49, 381-391.
26. Neill D. B., Grant L. D., and Grossman S. P. (1972) Selective potentiation of locomotor effects of amphetamine by midbrain raphe lesions. Physiol. Behav. 9, 655-657.
27. Nomikos G. G., Damsma G., Wenkstern D., and Fibiger H. C. (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6, 106-112.
28. Pan D., Gatley S. J., Dewey S. L., Chen R., Alexoff D. A., Ding Y.-S., and Fowler J. S. (1994) Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur. J. Pharmacol. 264, 177-182.
29. Parsons L. H. and Justice J. B. Jr. (1993) Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61, 1611-1619.
30. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, Sydney.
31. Ritz M. C., Lamb R. J., Goldberg S. R., and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
32. Ross S. B. (1979) The central stimulatory action of inhibitors of the dopamine uptake. Life Sci. 24, 159-168.
33. Santiago M. and Westerink B. H. C. (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch. Pharmacol. 342, 407-414.
34. 3H]Threo-(±)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J. Neurochem. 45, 1062-1070.
35. Segal D. S. (1976) Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy. Brain Res. 116, 267-276.
36. Segal D. S. (1977) Differential effects of serotonin depletion on amphetamine-induced locomotion and stereotypy, in Cocaine and Other Stimulants (Ellinwood E. H. and Kilbey M. J., eds), pp. 431-443. Raven Press, New York.
37. Segal D. S. and Kuczenski R. (1987) Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J. Pharmacol. Exp. Ther. 242, 917-926.
38. Segal D. S. and Kuczenski R. (1994) Behavioral pharmacology of amphetamine, in Amphetamine and Its Analogs: Psychopharmacology, Toxicology and Abuse (Cho A. K. and Segal D. S., eds), pp. 115-150. Academic Press, San Diego.
39. Stahle L., Segersvärd S., and Ungerstedt U. (1991) A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J. Pharmacol. Methods 25, 41-52.
40. Swonger A. K. and Rech R. H. (1972) Serotonergic and cholinergic involvement in habitation of activity and spontaneous alterations of rats in a Y maze. J. Comp. Physiol. Psychol. 81, 509-522.
41. Wages S. A., Church W. H., and Justice J. B. Jr. (1986) Sampling considerations for on-line microbore liquid chromatography of brain dialysis. Anal. Biochem. 58, 1649-1656.
42. Wall S. C., Gu H., and Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47, 544-550.
43. Westerink B. H. C. and De Vries J. B. (1988) Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J. Neurochem. 51, 683-687.
44. Woods S. K. and Meyer J. S. (1991) Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study. Brain Res. 560, 97-105.